Compare JSPR & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JSPR | REAL |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9M | 1.4B |
| IPO Year | 2019 | 2019 |
| Metric | JSPR | REAL |
|---|---|---|
| Price | $0.81 | $11.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 8 |
| Target Price | $15.50 | ★ $17.00 |
| AVG Volume (30 Days) | 2.1M | ★ 3.3M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 19.22 | ★ 43.55 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $692,845,000.00 |
| Revenue This Year | N/A | $14.30 |
| Revenue Next Year | N/A | $10.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.38 |
| 52 Week Low | $0.32 | $7.21 |
| 52 Week High | $3.13 | $17.39 |
| Indicator | JSPR | REAL |
|---|---|---|
| Relative Strength Index (RSI) | 60.42 | 45.55 |
| Support Level | $0.79 | $11.23 |
| Resistance Level | $1.05 | $12.00 |
| Average True Range (ATR) | 0.09 | 0.69 |
| MACD | 0.02 | -0.15 |
| Stochastic Oscillator | 66.32 | 17.09 |
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.
The RealReal Inc is an online marketplace for authenticated, resale luxury goods, providing an end-to-end service that unlocks supply and creates a trusted, curated marketplace for buyers globally. Since its inception, the company has cultivated a loyal and engaged consignor and buyer base through continuous investment in its technology platform, logistics infrastructure, brand and people. It offers a wide selection of authenticated, mainly pre-owned luxury goods bearing the brands of thousands of luxury and premium designers, including Cartier, Chanel, Christian Dior, Gucci, Hermes, Louis Vuitton and Rolex. The company offers products across women's fashion, men's fashion, jewelry, and watches, promoting the recirculation of luxury goods and contributing to a more sustainable world.